Effectiveness and safety of adalimumab in treating moderate to severe psoriasis patients with psoriatic arthritis in Taiwan

• Asıl Yazarlar: Pei-Han Kao (Yazar), Rosaline Chung-Yee Hui (Yazar), Chih-Hsun Yang (Yazar), Yu-Huei Huang (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Wolters Kluwer Medknow Publications, 2015-09-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background/Objective: The incidence of psoriasis vulgaris in Asians is estimated at 0.05-0.30%. Studies in North America and Europe demonstrated that adalimumab, a fully human monoclonal IgG1 antibody, is an efficacious treatment for psoriatic arthritis and chronic plaque psoriasis. The aim of this...